Replies to post #11116 on OrganiGram Holdings Inc (OGI)

[Hunchbackgeek]

Q1 F2023 ~ HIGHLIGHTS BELOW
• Maintained strong quarterly net revenue growth
• $43.3 million (?43% YoY) in Q1F23 compared to $30.4 million in Q1F22
• Fourth consecutive quarter of positive Adjusted EBITDA1
• Positive net income and operating cash flow
• Maintained #3 position among Canadian LPs2
• Launched HOLY MOUNTAIN, offering unique flower strains and pressed hash
• Secured a multi-year agreement to supply up to 20,000 kg of dry flower to Israel

FULL DETAILS https://investors.organigram.ca/investor-presentation

[Hunchbackgeek]

OGI ~OrganiGram "KEY INTERNATIONAL SUPPLY ARRANGEMENTS"...

• $5.9 million of flower revenue in Q1 F23, growing 71% from $3.4 million in Q1 F22
• High margin and not subject to excise tax
• Continued supply of dried flower to Canndoc for processing and distribution into Israeli medical
market1
• November 17, 2022: entered into a new multi-year Strategic Agreement with Canndoc to
supply up to 20,000kg of dry flower to Israel
• Opportunity to launch Organigram-branded medical products in Israel, and grants exclusivity
and related rights to Canndoc in Israel market
• Continued shipments made to Medcan and Cannatrek in Australia

The above information is located in OrganiGram's "Investor Presentation" download Page 28.
https://investors.organigram.ca/sites/default/files/documents/ogi_investors_Q1_2023_0.pdf

.